Common use of RESULTS AND PUBLICATIONS Clause in Contracts

RESULTS AND PUBLICATIONS. All TRIAL data and results, as well as resulting studies and patent rights, are property of the SPONSOR, and the Parties are bound to comply with relevant legislation. This does not preclude the PRINCIPAL INVESTIGATOR and the FOUNDATION from using the results in their professional activities. As per provisions of RD 223/2004, once the TRIAL is finished, the SPONSOR is bound to publish the results, whether positive of negative, in scientific media accessible to the public. If the SPONSOR has not published the TRIAL final results, the PRINCIPAL INVESTIGATOR can disseminate the data, discoveries or inventions through journals or scientific publications, making reference to the SPONSOR, at least. This shall be conducted according to following criteria: Trials on non-marketed products: during the first year, once authorized and marketed in any country; Trials conducted after product has been marketed, during the following year after the completion of the Trial, except when there is a commitment to publish the results in a medical journal submitted to peer review, or if there is an infringement to national law. The SPONSOR shall receive for his/her review, a copy of the text proposed for publication and/or dissemination, at least forty-five (45) days before it is sent to a scientific journal and at least twenty (20) days before it is summarized as an abstract. In any case, the PRINCIPAL INVESTIGATOR can only use this data subject to prior written authorization on purpose from the SPONSOR is issued.

RESULTS AND PUBLICATIONS. All TRIAL STUDY data and results, as well as resulting studies and patent rights, are property of the SPONSOR, and the Parties are bound to comply with relevant legislation. This does not preclude the PRINCIPAL INVESTIGATOR and the FOUNDATION from using the results in their professional activities. As per provisions of RD 223/2004, once Once the TRIAL STUDY is finished, the SPONSOR is bound to publish the results, whether positive of negative, in scientific media accessible to the public. If the SPONSOR has not published the TRIAL STUDY final results, the PRINCIPAL INVESTIGATOR can disseminate the data, discoveries or inventions through journals or scientific publications, making reference to the SPONSOR, at least. This shall be conducted according to following criteria: Trials Studys on non-marketed products: during the first year, once authorized and marketed in any country; Trials Studys conducted after product has been marketed, during the following year after the completion of the TrialStudy, except when there is a commitment to publish the results in a medical journal submitted to peer review, or if there is an infringement to national law. The SPONSOR shall receive for his/her review, a copy of the text proposed for publication and/or dissemination, at least forty-five (45) days before it is sent to a scientific journal and at least twenty (20) days before it is summarized as an abstract. In any case, the PRINCIPAL INVESTIGATOR can only use this data subject to prior written authorization on purpose from the SPONSOR is issued.